As much as we think that we are doing our best to take good care of our bodies, there are times that this may not be enough.. The truth is, eating healthy foods, having proper exercises and living a healthy lifestyle may sometimes not be enough to be secured that your body is shielded from certain kinds of illnesses. Other individuals may have considered that they’ve done enough, and having a regular check up is sometimes taken for granted. Breast cancer is one of the biggest reasons of human death most especially for women and is ranked 5th as the [...]
Posts Tagged ‘breast cancer treatment’
HER2 Breast Cancer Treatment
December 24th, 2011
Betty These advances have led to the adoption of ER and the estrogen-dependent gene PgR as powerful predictive factors for the odds of clinical response to endocrine therapy. It is now well established that hormone receptor–poor and especially negative breast cancer bracelets almost never respond to any form of endocrine therapy. That is, these breast cancers are resistant to all forms of endocrine therapy de novo. This resistance almost certainly occurs because the malignant phenotype of such tumors is independent of estrogen and instead dependent on other endocrine pathways. In this rapidly developing field, results suggest that these endocrine pathways are [...]
Breast Cancer Treatment And The Everett Clinic
December 20th, 2011
Betty Overview The Cancer Partnership is the result of a first-ever collaboration between four leading medical groups – Providence Everett Medical Center, The Everett Clinic, Western Washington Medical Group and Northwest Washington Radiation Oncology Associates. The Cancer Partnership hosts some of the most sought-after cancer technology never before available in the Puget Sound region. It offers all aspects of outpatient cancer care under one roof. In this interview, Dr. Soriano addresses breast cancer treatment, The Everett Clinic, and the Cancer Partnership. Interview with Dr. Perry Soriano MD, The Everett Clinic DR. SORIANO: We have a Cancer Conference, at the Cancer Partnership, [...]
What You Should Know About Breast Cancer
December 8th, 2011
Betty Why do females fear breast cancer more than any other disease? Because each year thousands of women develop breast cancer in our society and as scary as it sounds the percentage of breast cancer continues to rise. This type of cancer is very common in our society. Nevertheless, with the help of medical technologies, breast cancer is now 90% curable when diagnosed early. We do not know what causes breast cancer, although we do know that certain risk factors may put you at higher risk of developing it. A person’s age, factors of genetic, personal health history and diet all [...]
Basic Information About Breast Cancer
December 4th, 2011
Betty Breast cancer elicits numerous worries. You are afraid of loss of life, of dropping your body, or suffering as a result of an altered sexuality and so much extra. Managing this type of anxieties may be reduced through awareness and details of treatment and choices. That is the reason why each woman ought to talk about her circumstance using the physician so that you can make the very best decisions for her health. However stats expose that girls with the highest levels of anxiety likewise have one of the most intense kinds of tumors. panera bread product discounts Most sorts [...]
Breast Cancer Therapy: Standard Treatment Strategies
December 4th, 2011
Betty Your team of physicians will make remedy suggestions according to the stage of the cancer. Your common remedy selections might contain surgery, chemotherapy, radiation, and hormone treatment. For those who have been diagnosed with DCIS or LCIS, your stage will be the lowest and the road you’ll travel might be less difficult. For DCIS, your options may possibly consist of breast-conserving surgery or mastectomy with or without radiation and hormone treatment. LCIS remedies selections are a little distinct. They include observation to ascertain adjustments, hormone treatment to avoid cancer from developing, or bilateral prophylactic (preventive) mastectomies. Things get [...]
Treatment For Breast Cancer
November 29th, 2011
Betty First-generation aromatase inhibitors lacked specificity and were associated with substantial toxicity. However, powerful agents that specifically and almost completely inhibit aromatase activity are now in widespread use, and the results of recently published studies suggest that they may be even more effective than tamoxifen. Additive endocrine therapies, in principle, function by direct action on the hormonally dependent breast cancer recurrence cell. In that regard, estrogen production persists, but its action is blocked at the cellular stages by interfering with estrogen and its receptor. Enigmatically, the first such agents to be used successfully were estrogenic compounds (diethylstilbestrol, ethyinylestradiol) administered at [...]
Breast Cancer – Getting Endocrine Therapy
November 29th, 2011
Betty One could argue that the field of molecular medicine was initiated in the late 1890s, when Sir George Thomas Beatson, a surgeon at the Glasgow Infirmary, hypothesized the existence of a link between the breast and the ovary, since castration of dairy cattle enhances lactation. He offered oophorectomy to three young women with what would now be called locally advanced breast cancer. Remarkably, 2o of these three women experienced regression of their disease. Although Beatson concluded that this effect was secondary to a neurological link between the organs, we now know that he was removing a molecular growth factor [...]
Breast Cancer Medication And Treatment
November 28th, 2011
Betty Molecular biology of cancer sign and the ER-axis may also explain another puzzling clinical observation. During the first fifteen years of tamoxifen use, most clinicians assumed that long-term administration should be more effective than shorter courses. Indeed, prospective randomized trials and a worldwide overview of clinical results in cancer treatment centers have demonstrated that while 1 year of adjuvant tamoxifen improves disease-free and overall survival, 2 years and 5 years provide even more benefit. However, in two prospective trials in which women who reached 5 years on adjuvant tamoxifen were randomly assigned to ongoing maintenance versus discontinuation of the drug, [...]
The Breast Cancer Conference, Breast Cancer Treatment And The Everett Clinic
November 27th, 2011
Betty Overview The Cancer Partnership is the result of a first-ever collaboration between four leading medical groups – Providence Everett Medical Center, The Everett Clinic, Western Washington Medical Group and Northwest Washington Radiation Oncology Associates. The Cancer Partnership hosts some of the most sought-after cancer technology never before available in the Puget Sound region. It offers all aspects of outpatient cancer care under one roof. In this interview, Dr. Neuger addresses breast cancer treatment, The Everett Clinic, and communication between departments. Interview with Dr. Elizabeth L. Neuger, MD, The Everett Clinic INTERVIEWER: How do you coordinate care after the [...]
Breast Cancer Resistance To Endocrine Treatment
November 27th, 2011
Betty In spite of the considerable progress made, several important questions regarding ER-directed endocrine therapies remained unanswered. Foremost, one must wonder why all breast cancers are not equally responsive to ER disruption. The malignant phenotype of a substantial portion (up to 50%) of breast cancers appears to be hormone (estrogen)-independent; therefore, classic ER-directed endocrine therapy provides little or no benefit to such patients. Moreover, many patients whose tumors are initially hormone-dependent ultimately develop disease that is resistant to one or another of the endocrine strategies. Surprisingly, these symptoms of breast cancer may remain sensitive to alternative hormone treatments for some [...]
Endocrine Treatment For Breast Cancer
November 26th, 2011
Betty As the uncontrolled activation of cellular endocrine systems is characteristic of many breast cancers, endocrine therapy should be an effective and relatively nontoxic treatment. This chapter reviews the role of ablative and additive endocrine approaches to block estrogen synthesis and function. The occurrence of endocrine therapy–resistant cancers as well as the mechanisms involved in such resistance and possible approaches to overcome resistance of ovarian cancer symptoms are also discussed. The question “Why endocrine therapy?” begs a second query, “What is endocrine therapy?” In its purest sense, endocrine therapy is the modulation of signal transduction pathways initiated by interaction of [...]


Posted in
Tags: